Market Research News Global Anti-Viral Drug Market (2016-2024)- Researc | Page 4

By End User
Hospitals
Clinics
Others
By Region
• Global anti-viral drug market is further classified on the basis of region as follows:
• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth &
Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands &
Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, South Korea
& Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
• Middle East and Africa (GCC, North Africa, South Africa & Rest of Middle East and
Africa) Market Size and Y-O-Y Growth Analysis
Growth Drivers & Challenges
Rising number of HIV cases is expected to be one of the key growth drivers for anti-
viral drugs market. Further, rising awareness about this deadly diseases are
substantially raising the demand for the anti-viral drugs globally. According to WHO,
the number of people infected with HIV were estimated to be 36.7 Million in 2016.
Additionally, 1.8 Million new cases of HIV were registered in 2016. This high growth
in the number of HIV cases is believed to garner the growth of global anti-viral drugs
market.
Furthermore, research & development associated with the anti-viral drugs market is
expected to drive the growth of the anti-viral drugs market globally. Apart from this,
favorable government healthcare regulations are envisioned to bolster the growth of
the global anti-viral drugs market. In contrast, high cost of advanced developing anti-
viral drugs is anticipated to restrain the development of anti-viral drugs market.
Further, lack of awareness about the viral diseases is expected to limit the growth of
the global anti-aging market.
Copyright © Research Nester